Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone (Q44339977)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone |
scientific article |
Statements
1 reference
Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone (English)
1 reference
Ian S Zagon
1 reference
Joseph W Sassani
1 reference
Jessica A Immonen
1 reference
Patricia J McLaughlin
1 reference
29 July 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference